Aura Biosciences, Inc.·4

Jun 16, 4:30 PM ET

Gibney Anthony S 4

Research Summary

AI-generated summary

Updated

Aura (AURA) CFO Anthony Gibney Sells 12,824 Shares

What Happened
Anthony S. Gibney, Chief Financial and Business Officer of Aura Biosciences (AURA), reported a sale of 12,824 shares on 2026-06-16. The shares were disposed at $6.42 each, totaling about $82,330. The filing indicates these shares were sold to satisfy tax withholding obligations tied to vested restricted stock units (RSUs) and were automatic—not at the reporting person's discretion.

Key Details

  • Transaction date: 2026-06-16; Sale price: $6.42 per share; Shares sold: 12,824; Proceeds ≈ $82,330.
  • Transaction type: Sale (reported as "Open market or private sale," code S).
  • Footnote: Sales were automatic to cover tax withholding for RSU vesting (not a discretionary sale).
  • Shares owned after the transaction: Not specified in the provided filing excerpt.
  • Filing date: 2026-06-16 (filed same day as the transaction — timely filing).

Context
Sales to cover tax withholding on vested RSUs are routine administrative transactions and do not necessarily indicate a change in the insider's view of the company. For retail investors, purchases by insiders typically carry more weight as a bullish signal; routine tax-withholding sales are common and often unrelated to company performance.